WebMar 2, 2024 · Curis stock soars 34% as FDA lifts partial clinical hold on emavusertib's lymphoma study SA News Thu, Aug. 18, 2024 Curis GAAP EPS of -$0.17 in-line, revenue of $2.39M misses by $0.33M WebApr 5, 2024 · LEXINGTON, Mass., April 05, 2024 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug...
In 2024, Curis Inc. (NASDAQ: CRIS) Shares Will Likely Be Bullish
WebJun 11, 2024 · Curis Shares Drop After Updated CA-4948 Data From Mid-Stage Blood Cancer Trial Benzinga Jun. 11, 2024, 09:56 AM Curis Inc (NASDAQ:CRIS) has … WebApr 13, 2024 · Curis Inc. (NASDAQ:CRIS) shares, rose in value on Wednesday, 04/12/23, with the stock price up by 9.26% to the previous day’s close as strong demand from buyers drove the stock to $0.83. Actively observing the price movement in the last trading, the stock closed the session at $0.76, falling within a range of $0.73 and $0.849. doxycycline dosage for tooth abscess
Biotechnology (BK2069) Stock Price,News,Quote-Moomoo
WebApr 12, 2024 · The present stock price for Curis Inc. (CRIS) is $0.76. In the last trading session, the stock made a considerable jump, reaching $0.7694 after an opening price … WebOct 21, 2024 · Curis, Inc. ( NASDAQ: CRIS) is a small biotech company that is working on developing drugs to treat cancer. It has gotten hammered in 2024, plunging from a 52-week high of $7.63, to a low of... WebApr 5, 2024 · The latest price target for Curis ( NASDAQ: CRIS) was reported by HC Wainwright & Co. on Thursday, November 10, 2024. The analyst firm set a price target for 9.00 expecting CRIS to rise to within... doxycycline dose for anaplasmosis in dogs